Cytiva licenses advanced machine learning technology from Allen Institute

Cytiva and the Allen Institute have entered into a license agreement to integrate the Allen Institute's machine learning technology with Cytiva's microscopy and image analysis systems to advance the development of cell imaging innovations.

The Allen Institute's machine learning technology produces fluorescence signal images from transmitted-light microscopy without the use of fluorescent dye reagents or genetically encodable fluorescent proteins.

The method provides benefits of both fluorescent imaging and a label-free approach, achieving a clear image of cellular and subcellular structures without the cytotoxic effects and experimental limitations associated with live cell fluorescence microscopy.

The technique further enables live cell imaging in three-dimensional (3D) space to generate more physiologically relevant information about biological processes and underlying mechanisms of disease.

This builds on the excellence of our research, teaming up with a leader in imaging and cell analysis systems. Our mission is to pursue complex scientific problems collaboratively with the ultimate goal of translating our research and technologies for impact in healthcare and life science research applications. Our cell and neuroscience teams are pioneering new approaches to visualize cell organization, dynamics, and activities."

Todd Peterson, Ph.D., Chief Scientific Officer, Allen Institute

The combination of technologies under the license will enable life scientists and other researchers to harness the power of label-free imaging and to advance 3D cellular analysis through integrated product solutions and leading customer support from Cytiva.

Emmanuel Abate, Vice President, Genomics and Cellular Research at Cytiva, says: "This highly promising technology has the potential to advance microscopy by enabling label-free cell imaging."

"For scientists to be able to see their samples less invasively would accelerate results in areas such as fundamental human biological research and drug efficacy studies. We look forward to developing it in the future to realize this potential."

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Cytiva Life Sciences. (2023, May 17). Cytiva licenses advanced machine learning technology from Allen Institute. News-Medical. Retrieved on June 16, 2024 from https://www.news-medical.net/news/20200806/Cytiva-licenses-Allen-Institute-to-advance-the-development-of-cell-imaging-innovations.aspx.

  • MLA

    Cytiva Life Sciences. "Cytiva licenses advanced machine learning technology from Allen Institute". News-Medical. 16 June 2024. <https://www.news-medical.net/news/20200806/Cytiva-licenses-Allen-Institute-to-advance-the-development-of-cell-imaging-innovations.aspx>.

  • Chicago

    Cytiva Life Sciences. "Cytiva licenses advanced machine learning technology from Allen Institute". News-Medical. https://www.news-medical.net/news/20200806/Cytiva-licenses-Allen-Institute-to-advance-the-development-of-cell-imaging-innovations.aspx. (accessed June 16, 2024).

  • Harvard

    Cytiva Life Sciences. 2023. Cytiva licenses advanced machine learning technology from Allen Institute. News-Medical, viewed 16 June 2024, https://www.news-medical.net/news/20200806/Cytiva-licenses-Allen-Institute-to-advance-the-development-of-cell-imaging-innovations.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.